ACRO BIOMEDICAL CO., LTD. (ACBM) Net margin 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) net profit margin by fiscal year — reported net income divided by reported revenue.
-2410.2%FY2022 · since FY2017: -0.4% → -2410.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -2410.2% | -1767.4 pp |
| FY2021 | -642.8% | -625.8 pp |
| FY2020 | -17.1% | +174.9 pp |
| FY2019 | -192.0% | -197.2 pp |
| FY2018 | 5.2% | +5.7 pp |
| FY2017 | -0.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Gross profitACBM Gross marginACBM Operating incomeACBM Operating marginACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →